
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (09): 1080-1085.DOI: 10.12114/j.issn.1007-9572.2022.0578
Special Issue: 骨质疏松最新文章合辑; 骨健康最新文章合辑
• Article • Previous Articles Next Articles
Received:2022-06-25
Revised:2022-10-25
Published:2023-03-20
Online:2022-12-01
Contact:
HUANG Hongxing
通讯作者:
黄宏兴
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0578
| 年龄(岁) | 例数 | 身高(m) | 体质量(kg) | BMI(kg/m2) | T值 |
|---|---|---|---|---|---|
| 49~58 | 31 | 1.58±0.06 | 54.46±6.83 | 21.63±2.70 | -1.65±1.26 |
| 59~68 | 57 | 1.57±0.05 | 55.21±7.59 | 22.33±3.08 | -2.34±1.42a |
| ≥69 | 20 | 1.56±0.06 | 56.08±8.13 | 22.96±3.23 | -2.73±1.31a |
| F值 | 1.30 | 0.29 | 1.26 | 4.40 | |
| P值 | 0.28 | 0.75 | 0.29 | 0.02 |
Table 1 Comparison of height,weight,BMI and T-score between subjects in three age groups
| 年龄(岁) | 例数 | 身高(m) | 体质量(kg) | BMI(kg/m2) | T值 |
|---|---|---|---|---|---|
| 49~58 | 31 | 1.58±0.06 | 54.46±6.83 | 21.63±2.70 | -1.65±1.26 |
| 59~68 | 57 | 1.57±0.05 | 55.21±7.59 | 22.33±3.08 | -2.34±1.42a |
| ≥69 | 20 | 1.56±0.06 | 56.08±8.13 | 22.96±3.23 | -2.73±1.31a |
| F值 | 1.30 | 0.29 | 1.26 | 4.40 | |
| P值 | 0.28 | 0.75 | 0.29 | 0.02 |
| 年龄(岁) | 例数 | 脂肪质量(g) | 肌肉质量(g) | 脂肪百分比(%) | 骨矿含量(g) |
|---|---|---|---|---|---|
| 49~58 | 31 | 18 664.01±4 133.41 | 34 070.78±3 356.28 | 33.49±4.77 | 1 715.36±233.90 |
| 59~68 | 57 | 18 313.35±4 159.07 | 35 110.87±5 178.73 | 33.14±4.76 | 1 613.11±312.45 |
| ≥69 | 20 | 18 404.96±4 050.80 | 35 495.88±6 179.41 | 33.23±6.13 | 1 536.87±300.01 |
| F值 | 0.07 | 0.63 | 0.05 | 2.47 | |
| P值 | 0.93 | 0.53 | 0.95 | 0.09 |
Table 2 Comparison of fat mass,muscle mass,fat percentage and bone mineral content in subjects in three age groups
| 年龄(岁) | 例数 | 脂肪质量(g) | 肌肉质量(g) | 脂肪百分比(%) | 骨矿含量(g) |
|---|---|---|---|---|---|
| 49~58 | 31 | 18 664.01±4 133.41 | 34 070.78±3 356.28 | 33.49±4.77 | 1 715.36±233.90 |
| 59~68 | 57 | 18 313.35±4 159.07 | 35 110.87±5 178.73 | 33.14±4.76 | 1 613.11±312.45 |
| ≥69 | 20 | 18 404.96±4 050.80 | 35 495.88±6 179.41 | 33.23±6.13 | 1 536.87±300.01 |
| F值 | 0.07 | 0.63 | 0.05 | 2.47 | |
| P值 | 0.93 | 0.53 | 0.95 | 0.09 |
| 组别 | 例数 | 脂肪质量(g) | 肌肉质量(g) | 脂肪百分比(%) | 骨矿含量(g) |
|---|---|---|---|---|---|
| 正常组 | 20 | 19 765.63±5 214.64 | 35 780.18±5 093.34 | 33.25±5.95 | 2 022.73±223.09 |
| 骨量减少组 | 38 | 19 086.44±4 154.20 | 36 202.62±4 881.37 | 33.37±5.65 | 1 712.66±168.10a |
| 骨质疏松组 | 50 | 17 398.95±3 304.62a | 33 522.57±4 622.30b | 33.18±4.08 | 1 406.50±169.09ab |
| F值 | 3.27 | 3.79 | 0.02 | 90.41 | |
| P值 | 0.04 | 0.03 | 0.98 | 0.00 |
Table 3 Comparison of fat mass,muscle mass,fat percentage and bone mineral content in normal group,bone loss group and osteoporosis group
| 组别 | 例数 | 脂肪质量(g) | 肌肉质量(g) | 脂肪百分比(%) | 骨矿含量(g) |
|---|---|---|---|---|---|
| 正常组 | 20 | 19 765.63±5 214.64 | 35 780.18±5 093.34 | 33.25±5.95 | 2 022.73±223.09 |
| 骨量减少组 | 38 | 19 086.44±4 154.20 | 36 202.62±4 881.37 | 33.37±5.65 | 1 712.66±168.10a |
| 骨质疏松组 | 50 | 17 398.95±3 304.62a | 33 522.57±4 622.30b | 33.18±4.08 | 1 406.50±169.09ab |
| F值 | 3.27 | 3.79 | 0.02 | 90.41 | |
| P值 | 0.04 | 0.03 | 0.98 | 0.00 |
| 组别 | 例数 | Ca(mmol/L) | OPG(ng/L) | BMP2(ng/L) | BCL2(μg/L) |
|---|---|---|---|---|---|
| 正常组 | 20 | 1.24±0.19 | 3 665.67±3 139.33 | 653.47±184.44 | 161.88±158.01 |
| 骨量减少组 | 38 | 1.28±0.19 | 3 352.63±3 044.51 | 458.87±262.95a | 173.93±154.43 |
| 骨质疏松组 | 50 | 1.23±0.18 | 2 062.60±1 474.09ab | 441.45±322.46a | 106.67±60.08b |
| F值 | 0.80 | 4.43 | 4.35 | 3.73 | |
| P值 | 0.45 | 0.01 | 0.02 | 0.03 |
Table 4 Comparison of bone formation indices in normal group,bone loss group and osteoporosis group
| 组别 | 例数 | Ca(mmol/L) | OPG(ng/L) | BMP2(ng/L) | BCL2(μg/L) |
|---|---|---|---|---|---|
| 正常组 | 20 | 1.24±0.19 | 3 665.67±3 139.33 | 653.47±184.44 | 161.88±158.01 |
| 骨量减少组 | 38 | 1.28±0.19 | 3 352.63±3 044.51 | 458.87±262.95a | 173.93±154.43 |
| 骨质疏松组 | 50 | 1.23±0.18 | 2 062.60±1 474.09ab | 441.45±322.46a | 106.67±60.08b |
| F值 | 0.80 | 4.43 | 4.35 | 3.73 | |
| P值 | 0.45 | 0.01 | 0.02 | 0.03 |
| [1] |
|
| [2] |
|
| [3] |
中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.DOI:10.1016/j.jbspin.2018.08.001.
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
庞同涛. 骨质疏松发病与Bcl-2、CXCL12基因表达的关系[D]. 济南:山东大学,2018.
|
| [31] |
黄宏兴,柴爽,黄红,等. 沉默Bcl2、Bak1基因表达对成骨肉瘤MG-63细胞增殖及成骨能力的影响[J]. 山东医药,2018,58(16):34-36. DOI:10.3969/j.issn.1002-266X.2018.16.009.
|
| [32] |
黄宏兴,柴爽,黄红,等. Bcl2及Bak1重组表达腺病毒对MG63细胞的影响[J]. 中国骨质疏松杂志,2018,24(6):701-705. DOI:10.3969/j.issn.1006-7108.2018.06.001.
|
| [33] |
王吉利,张志海,黄宏兴,等. Bcl2促进UMR-106细胞BMP-2、OPG表达及补肾健脾活血方对其影响[J]. 中国骨质疏松杂志,2018,24(7):841-846,873. DOI:10.3969/j.issn.1006-7108.2018.07.001.
|
| [1] | LIN Yanping, HUANG Jiachun, GUO Haiwei, ZHAO Rui, YANG Haolin, WAN Lei, ZHU Genfu, HUANG Hongxing. Study on the Distribution of TCM Syndrome Types and the Relationship between Muscle-bone-lipid in Patients with Primary Osteoporosis [J]. Chinese General Practice, 2026, 29(21): 3040-3045. |
| [2] | LI Shilong, WANG He, ZHOU Xiaoyu, FU Lei, ZHAO Zhuo, HUA Chengjun, SI Chunying. Advances in the Study of Cardiac Macrophages in Heart Failure with Preserved Ejection Fraction [J]. Chinese General Practice, 2026, 29(15): 2084-2091. |
| [3] | HE Xiaoming, HE Mincong, WEI Tengfei, LIN Tianye, LIU Wengang, ZHANG Qingwen, HE Wei, WEI Qiushi. Multidimensional Relationship of "TCM Syndrome Type, Clinical Feature and Molecular Typing" in Postmenopausal Patients with Knee Osteoarthritis [J]. Chinese General Practice, 2026, 29(12): 1588-1598. |
| [4] | ZHANG Hanzhi, JIN Hua, MA Le, SHI Ling, CHEN Chen, HUAN Hongmei, YU Dehua. Analysis of the Quality of Diagnosis and Treatment of Osteoporosis in Shanghai Community Health Service Institutions [J]. Chinese General Practice, 2026, 29(12): 1548-1557. |
| [5] | YANG Yang, GAO Xi. Research Progress of Paradoxical Bone Formation in Osteoporosis [J]. Chinese General Practice, 2026, 29(09): 1217-1224. |
| [6] | ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali. Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(29): 3653-3659. |
| [7] | GAO Guiying, HU Yang, ZHANG Shiyi, MENG Yi, DENG Jie. Research Progress on the Mechanism of Exercise Rehabilitation in Improving Coronary Microcirculation Disorder [J]. Chinese General Practice, 2025, 28(20): 2570-2576. |
| [8] | XIONG Xin, LI Yang, SHI Feng, YANG Lian, DUAN Wei, CHEN Bei, LI Yong, ZHAO Linwei, FU Quanshui, FAN Xiaoping, YANG Guoqing. Research on the Measurement System and Calibration of Thoracolumbar Vertebral Density Based on Artificial Intelligence [J]. Chinese General Practice, 2025, 28(19): 2398-2406. |
| [9] | TAN Wenbin, LI Jia, LIU Mingyu, LU Yongxin, CHENG Yaxin. Research Progress on the Influence of Nervous System Diseases and Related Therapeutic Drugs on Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2092-2100. |
| [10] | HE Ting, LI Jia, TAN Wenbin. Research Progress of Circulatory System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2101-2112. |
| [11] | CHEN Beibei, LI Jia, TAN Wenbin. Progress in the Research of Endocrine and Metabolic System Diseases and Secondary Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2082-2091. |
| [12] | LI Jia, TAN Wenbin. The Dilemma of Prevention and Treatment of Secondary Osteoporosis and Its Countermeasures [J]. Chinese General Practice, 2025, 28(17): 2075-2081. |
| [13] | SUN Qing, WU Yuxiao, CUI Limin. The Prevalence of Osteosarcopenia in Chinese Patients with Type 2 Diabetes Mellitus: a Meta-analysis [J]. Chinese General Practice, 2025, 28(12): 1520-1526. |
| [14] | YANG Chaofu, TAN Guoqing, XU Zhanwang. Research Progress on the Regulation Mechanism of Senescence-associated Secretory Phenotype in Osteoporosis [J]. Chinese General Practice, 2024, 27(29): 3685-3695. |
| [15] | SU Jin, SHOU Juan, GU Wenqin, YI Chuntao, XU Liping, CHENG Lili, DING Hongjuan, ZHOU Peng, WU Yinghua, QIN Jie, XUE Bin, WEI Baichuan, WANG Qian, PENG Yan, CHENG Yimin, YANG Lan, WEI Yangyang, WANG Lei, QI Jinlin, SHAO Ying, CAI Liming. Cost Effectiveness Analysis of the Prevention and Treatment of Osteoporosis among the Entire Population in Fenglin Community, Shanghai Based on Markov Chain [J]. Chinese General Practice, 2024, 27(22): 2789-2796. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||